相关实验视频

Updated: May 12, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

与黑色素瘤迁移相关的生物活性表位的功能性体进化启用阐明

Hong Xuan¹, Siqi Bian¹, Qinguo Liu¹

¹State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

Acta pharmaceutica Sinica. B

|July 14, 2025

概括

研究人员开发了一个新的平台,以找到黑色素瘤目标. 他们确定了地硫酸蛋白质甘4 (CSPG4) 作为黑色素瘤细胞迁移中的关键蛋白质,为新疗法铺平了道路.

科学领域:

生物化学生化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

转移是皮肤黑色素瘤患者的主要死亡原因.
确定转移相关的点和治疗策略对于黑色素瘤治疗至关重要.
亚胺为探索细胞表面蛋白质和开发向疗法提供了一种有前途的方法.

研究的目的:

开发和验证一个新的平台,功能性体进化启用目标识别 (FAETI),用于发现黑色素瘤中转移相关的目标和表位.
使用FAETI平台识别与黑色素瘤细胞迁移有关的特定蛋白质标.
描述一个功能性胺体 (XH3C) 抑制黑色素瘤细胞迁移的机制.

主要方法:

与表型查和标蛋白鉴定集成的aptamer选择,以创建FAETI平台.
对黑色素瘤细胞迁移抑制功能的选阿普坦.
通过生物化学和细胞检测确定了标蛋白和特征化了aptamer-target相互作用.

主要成果:

在FAETI平台上,成功地确定了里素硫酸蛋白甘4 (CSPG4) 作为黑色素瘤迁移中的潜在目标.
亚胺XH3C通过向CSPG4.4上的特定表位体,显示出一种抑制迁移的功能.
已经证明,XH3C通过阻断CSPG4与整体素α4.4之间的相互作用来诱导细胞骨重组.

结论:

这项研究验证了基于aptamer的工具在黑色素瘤中发现标和表皮质的稳定性.
CSPG4被确定为在黑色素瘤转移中治疗干预的重要目标.
由于其特定的结合性和功能性活性,阿帕特马XH3C代表了黑色素瘤治疗的潜在治疗候选者.

关键词:

亚普特美尔 (Aptamer) 是一种药物.CSPG4 CSPG4 在线阅读顺德罗因丁硫酸盐链条细胞骨的重新安排菲蒂蒂菲蒂是什么意思黑色素瘤迁移的迁移情况现型查现型查现型查目标和表位发现的发现.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...